Alnylam Pharmaceuticals Inc. (ALNY): Price and Financial Metrics
ALNY Price/Volume Stats
| Current price | $287.76 | 52-week high | $304.39 |
| Prev. close | $290.70 | 52-week low | $141.98 |
| Day low | $285.68 | Volume | 351,912 |
| Day high | $292.62 | Avg. volume | 764,716 |
| 50-day MA | $258.63 | Dividend yield | N/A |
| 200-day MA | $253.83 | Market Cap | 37.25B |
ALNY Stock Price Chart Interactive Chart >
Alnylam Pharmaceuticals Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics[3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.[4] In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. (Source:Wikipedia)
ALNY Price Returns
| 1-mo | 14.83% |
| 3-mo | N/A |
| 6-mo | 4.80% |
| 1-year | 89.23% |
| 3-year | 75.67% |
| 5-year | 168.41% |
| YTD | 22.29% |
| 2024 | 22.94% |
| 2023 | -19.46% |
| 2022 | 40.14% |
| 2021 | 30.48% |
| 2020 | 12.85% |
Continue Researching ALNY
Want to do more research on Alnylam Pharmaceuticals Inc's stock and its price? Try the links below:Alnylam Pharmaceuticals Inc (ALNY) Stock Price | Nasdaq
Alnylam Pharmaceuticals Inc (ALNY) Stock Quote, History and News - Yahoo Finance
Alnylam Pharmaceuticals Inc (ALNY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...